Mycoplasma pneumoniae infection and environmental tobacco smoke inhibit lung glutathione adaptive responses and increase oxidative stress

Infection and Immunity

Volumn 76, Issue 10, 2008, Pages 4455-4462

  Kariya, Chirag ^a,b   Hong, Wei Chu ^a,b   Huang, Jie ^b   Leitner, Heather ^a,b   Martin, Richard J ^a,b   Day, Brian J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; TOBACCO SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LUNG; MOUSE; MYCOPLASMA PNEUMONIA; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; BODY FLUIDS; CELL LINE; DNA; EPITHELIAL CELLS; GLUTATHIONE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; MYCOPLASMA PNEUMONIAE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PNEUMONIA, MYCOPLASMA; RESPIRATORY MUCOSA; SMOKE;

EID: 53649086809     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00136-08     Document Type: Article

References (51)

1. Almagor, M., I. Kahane, C. Gilon, and S. Yatziv. 1986. Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae. Infect. Immun. 52:240-244.
2. Almagor, M., S. Yatziv, and I. Kahane. 1983. Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Infect. Immun. 41:251-256.
3. Bilimoria, M. H., and D. J. Ecobichon. 1992. Protective antioxidant mechanisms in rat and guinea pig tissues challenged by acute exposure to cigarette smoke. Toxicology 72:131-144.
4. Cantin, A. M., G. Bilodeau, C. Ouellet, J. Liao, and J. W. Hanrahan. 2006. Oxidant stress suppresses CFTR expression. Am. J. Physiol. Cell Physiol. 290:C262-C270.
5. Cantin, A. M., J. W. Hanrahan, G. Bilodeau, L. Ellis, A. Dupuis, J. Liao, J. Zielenski, and P. Durie. 2006. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am. J. Respir. Crit. Care Med. 173:1139-1144.
6. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152-157.
7. Carnevali, S., S. Petruzzelli, B. Longoni, R. Vanacore, R. Barale, M. Cipollini, F. Scatena, P. Paggiaro, A. Celi, and C. Giuntini. 2003. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L955-L963.
8. Cassell, G. H., and B. C. Cole. 1981. Mycoplasmas as agents of human disease. N. Engl. J. Med. 304:80-89.
9. Cherry, J. D., D. Taylor-Robinson, H. Willers, and A. C. Stenhouse. 1971. A search for mycoplasma infections in patients with chronic bronchitis. Thorax 26:62-67.
10. Chinard, F. P. 1992. Quantitative assessment of epithelial lining fluid in the lung. Am. J. Physiol. 263:L617-L618.
11. Chu, H. W., R. Breed, J. G. Rino, R. J. Harbeck, M. R. Sills, and R. J. Martin. 2006. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background. Microbes Infect. 8:1764-1772.
12. Cotgreave, I. A., U. Johansson, P. Moldeus, and R. Brattsand. 1987. The effect of acute cigarette smoke inhalation on pulmonary and systemic cysteine and glutathione redox states in the rat. Toxicology 45:203-212.
13. Crystal, R. G. 1991. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am. J. Med. 91:39S-44S.
14. Daxboeck, F., R. Krause, and C. Wenisch. 2003. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect. 9:263-273.
15. Day, B. J., A. M. van Heeckeren, E. Min, and L. W. Velsor. 2004. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary Pseudomonas infection. Infect. Immun. 72:2045-2051.
16. Flotte, T. R., S. A. Afione, R. Solow, M. L. Drumm, D. Markakis, W. B. Guggino, P. L. Zeitlin, and B. J. Carter. 1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268:3781-3790.
17. Folkerts, G., J. Kloek, R. B. Muijsers, and F. P. Nijkamp. 2001. Reactive nitrogen and oxygen species in airway inflammation. Eur. J. Pharmacol. 429:251-262.
18. Gil, J. C., R. L. Cedillo, B. G. Mayagoitia, and M. D. Paz. 1993. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy 70:23-25.
19. Gupta, S., L. K. Rogers, S. K. Taylor, and C. V. Smith. 1997. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol. Appl. Pharmacol. 146:317-327.
20. Hahn, D. L. 1998. Chlamydia pneumoniae and asthma. Thorax 53:1095-1096.
21. Hickman-Davis, J. M., C. McNicholas-Bevensee, I. C. Davis, H. P. Ma, G. C. Davis, C. A. Bosworth, and S. Matalon. 2006. Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. Am. J. Respir. Crit. Care Med. 173:334-344.
22. Howard, D. J., L. A. Briggs, and C. A. Pritsos. 1998. Oxidative DNA damage in mouse heart, liver, and lung tissue due to acute side-stream tobacco smoke exposure. Arch. Biochem. Biophys. 352:293-297.
23. Ishizaki, T., Y. Kishi, F. Sasaki, S. Ameshima, T. Nakai, and S. Miyabo. 1996. Effect of probucol, an oral hypocholesterolaemic agent, on acute tobacco smoke inhalation in rats. Clin. Sci. (London) 90:517-523.
24. Jones, D. P. 2002. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348:93-112.
25. Kogan, I., M. Ramjeesingh, C. Li, J. F. Kidd, Y. Wang, E. M. Leslie, S. P. Cole, and C. E. Bear. 2003. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J. 22:1981-1989.
26. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158:998-1001.
27. Lambert, H. P. 1968. Antibody to Mycoplasma pneumoniae in normal subjects and in patients with chronic bronchitis. J. Hyg. (London) 66:185-189.
28. Lieberman, D., M. Ben-Yaakov, Z. Lazarovich, S. Hoffman, B. Ohana, M. G. Friedman, B. Dvoskin, M. Leinonen, and I. Boldur. 2001. Infectious etiologies in acute exacerbation of COPD. Diagn. Microbiol. Infect. Dis. 40:95-102.
29. 2 formation of Mycoplasma pneumoniae. J. Bacteriol. 116:346-354.
30. Lyakhovich, V. V., V. A. Vavilin, N. K. Zenkov, and E. B. Menshchikova. 2006. Active defense under oxidative stress. The antioxidant responsive element. Biochemistry (Moscow) 71:962-974.
31. Meloni, F., E. Paschetto, P. Mangiarotti, M. Crepaldi, M. Morosini, A. Bulgheroni, and A. Fietta. 2004. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J. Chemother. 16:70-76.
32. Mogulkoc, N., S. Karakurt, B. Isalska, U. Bayindir, T. Celikel, V. Korten, and N. Colpan. 1999. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am. J. Respir. Crit. Care Med. 160:349-353.
33. Morrison, D., I. Rahman, S. Lannan, and W. MacNee. 1999. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am. J. Respir. Crit. Care Med. 159:473-479.
34. Neurohr, C., A. G. Lenz, I. Ding, H. Leuchte, T. Kolbe, and J. Behr. 2003. Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers. Eur. Respir. J. 22:82-87.
35. Park, E. M., Y. M. Park, and Y. S. Gwak. 1998. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic. Biol. Med. 25:79-86.
36. Pryor, W. A., and K. Stone. 1993. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 686:12-27.
37. Rahman, I., A. Bel, B. Mulier, M. F. Lawson, D. J. Harrison, W. Macnee, and C. A. Smith. 1996. Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem. Biophys. Res. Commun. 229:832-837.
38. Rahman, I., S. K. Biswas, and A. Kode. 2006. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 533:222-239.
39. Rahman, Q., P. Abidi, F. Afaq, D. Schiffmann, B. T. Mossman, D. W. Kamp, and M. Athar. 1999. Glutathione redox system in oxidative lung injury. Crit. Rev. Toxicol. 29:543-568.
40. Repine, J. E., A. Bast, I. Lankhorst, et al. 1997. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 156:341-357.
41. Singh, A., T. Rangasamy, R. K. Thimmulappa, H. Lee, W. O. Osburn, R. Brigelius-Flohe, T. W. Kensler, M. Yamamoto, and S. Biswal. 2006. Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am. J. Respir. Cell Mol. Biol. 35:639-650.
42. Snider, G. L. 1989. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Annu. Rev. Med. 40:411-429.
43. Teig, N., A. Anders, C. Schmidt, C. Rieger, and S. Gatermann. 2005. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax 60:962-966.
44. Tietze, F. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:502-522.
45. van der Vliet, A., and C. E. Cross. 2000. Oxidants, nitrosants, and the lung. Am. J. Med. 109:398-421.
46. Velsor, L. W., C. Kariya, R. Kachadourian, and B. J. Day. 2006. Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am. J. Respir. Cell Mol. Biol. 35:579-586.
47. Velsor, L. W., A. van Heeckeren, and B. J. Day. 2001. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L31-L38.
48. Vineis, P., M. Alavanja, and S. Garte. 2004. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int. J. Cancer 108:2-7.
49. Von Hertzen, L., H. Alakarppa, R. Koskinen, K. Liippo, H. M. Surcel, M. Leinonen, and P. Saikku. 1997. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol. Infect. 118:155-164.
50. Witschi, H., I. Espiritu, R. R. Maronpot, K. E. Pinkerton, and A. D. Jones. 1997. The carcinogenic potential of the gas phase of environmental tobacco smoke. Carcinogenesis 18:2035-2042.
51. Yang, S. R., A. S. Chida, M. R. Bauter, N. Shafiq, K. Seweryniak, S. B. Maggirwar, I. Kilty, and I. Rahman. 2006. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 291:L46-L57.